{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-453913","form_type":"8-K","ticker":"LNTH","cik":"0001521036","company_name":"Lantheus Holdings, Inc.","filed_at":"2026-11-09T22:40:18+00:00","discovered_at":"2026-11-10T11:05:00.213055+00:00","generated_at":"2026-11-10T11:05:06.393601+00:00","sec_items":["8.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Lantheus to sell CDMO business and Springfield, NJ plant to PharmaLogic; signs Lu-177 dotatate supply deal","bullets":["Definitive agreement dated Nov. 8, 2026 to sell Lantheus's contract development and manufacturing organization (CDMO) business and its Springfield, New Jersey facility to PharmaLogic Holdings Corp.","No purchase price or other financial terms disclosed; closing is subject to customary closing conditions and regulatory approvals.","Under a long-term supply agreement, PharmaLogic's therapeutic CDMO franchise Agilera will manufacture lutetium Lu 177 dotatate for Lantheus.","Lantheus will provide certain transition services to PharmaLogic immediately after closing.","Company flags risks that conditions may not be satisfied and that anticipated benefits may take longer to realize or involve unexpected costs."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-453913","json":"https://secwatch.observer/filing/0001193125-26-453913.json","markdown":"https://secwatch.observer/filing/0001193125-26-453913.md","text":"https://secwatch.observer/filing/0001193125-26-453913.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1521036/000119312526453913/0001193125-26-453913-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1521036/000119312526453913/d166239d8k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-11-10T11:05:06.393601+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}